Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
Bolt Medical’s $900 Million of Acquisition of Boston Scientific
USANA Health Sciences’ Acquisition of Hiya Health
Wilson Sonsini Goodrich & Rosati advised USANA Health Sciences, while Bodman PLC acted as Hiya’s legal advisor. Fried Frank acted as counsel to BofA Securities as...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Insilico Medicine’s $80 Million Agreement with Exelixis
Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the transaction. Exelixis, Inc. and Insilico Medicine announced that they have entered into an exclusive license agreement granting Exelixis...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...